Trial · NCT07899307
Metformin in Acute Ischemic Stroke
NCT07899307, Phase 3, Not yet recruiting, All India Institute of Medical Sciences
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Metformin in Acute Ischemic Stroke. Trials, record NCT07899307. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07899307
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Metformin in Acute Ischemic Stroke
- NCT number
- NCT07899307
- Status
- Not yet recruiting
- Phases
- Phase 3
- Enrollment
- 440 participants, estimated
- Lead sponsor
- All India Institute of Medical Sciences
- Conditions
- Acute Ischemic Stroke
- Interventions
- Placebo, Metfomin
- First posted
- 2026-10-27
- Last updated
- 2026-10-29
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | modified Rankin Scale (0 to 6, with 0 being no disability and 6 being death) | 90 days | Good outcome (defined as modified Rankin Scale of 0-1) at 90 days |
| Secondary | modified Rankin Scale (0 to 6, with 0 being no disability and 6 being death) | 30 days | Patients with good modified Rankin Scale (0-1) at 30 days |
| Secondary | Mortality | 30 days | Death at 30 days |
| Secondary | Mortality | 90 days | Death at 90 days |
| Secondary | Barthel Index (0 to 100 with 0 being completely dependent to 100 being completely independent) | 30 days | Barthel Index at 30 days |
| Secondary | Barthel Index (0 to 100 with 0 being completely dependent to 100 being completely independent) | 90 days | Barthel Index at 90 days |
| Secondary | Early neurological improvement (ENI) | 7 days | Proportion of patients with early neurological improvement (ENI) (improvement of \>=4 points in national institute of health stroke scale (NIHSS)) |
| Secondary | Early neurological deterioration (END) | 7 days | Proportion of patients with early neurological deterioration (END) (deterioration of \>=2 points national institute of health stroke scale (NIHSS)) at 7 days |
| Secondary | high sensitivity C-reactive protein (hs-CRP) | 30 days | Level of hsCRP |
| Secondary | high sensitivity C-reactive protein (hs-CRP) | 90 days | Level of hs-CRP |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07899307
GET https://conductscience.org/api/trials/v1/NCT07899307/registered